Journal
CANCER BIOLOGY & THERAPY
Volume 20, Issue 10, Pages 1304-1313Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/15384047.2019.1632637
Keywords
UNC-45A; microtubules; co-localization; interphase
Categories
Funding
- Department of Defense Ovarian Cancer Research Program [OC160377]
- Minnesota Ovarian Cancer Alliance
- Randy Shaver Cancer Research and Community Fund grant
- Ovarian Cancer Research Fund Grant
- University of Minnesota Grand Challenges Grant
- Litman Family Fund for Cancer Research
- Randy Shaver Cancer Research and Community Fund
- Minnesota Masonic Charities
- Masonic Cancer Center [P30 CA77598]
- Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota
- CDMRP [OC160377, 917602] Funding Source: Federal RePORTER
Ask authors/readers for more resources
UNC-45A is an ubiquitously expressed protein highly conserved throughout evolution. Most of what we currently know about UNC-45A pertains to its role as a regulator of the actomyosin system. However, emerging studies from both our and other laboratories support a role of UNC-45A outside of actomyosin regulation. This includes studies showing that UNC-45A: regulates gene transcription, co-localizes and biochemically co-fractionates with gamma tubulin and regulates centrosomal positioning, is found in the same subcellular fractions where MT-associated proteins are, and is a mitotic spindle-associated protein with MT-destabilizing activity in absence of the actomyosin system. Here, we extended our previous findings and show that UNC45A is variably expressed across a spectrum of cell lines with the highest level being found in HeLa cells and in ovarian cancer cells inherently paclitaxel-resistant. Furthermore, we show that UNC-45A is preferentially expressed in epithelial cells, localizes to mitotic spindles in clinical tumor specimens of cancer and co-localizes and co-fractionates with MTs in interphase cells independent of actin or myosin. In sum, we report alteration of UNC45A localization in the setting of chemotherapeutic treatment of cells with paclitaxel, and localization of UNC45A to MTs both in vitro and in vivo. These findings will be important to ongoing and future studies in the field that further identify the important role of UNC45A in cancer and other cellular processes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available